MorphoSys AG ADR Alpha and Beta Analysis
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as MorphoSys AG ADR. It also helps investors analyze the systematic and unsystematic risks associated with investing in MorphoSys over a specified time horizon. Remember, high MorphoSys' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to MorphoSys' market risk premium analysis include:
Beta (0.09) | Alpha 0.0844 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
MorphoSys |
MorphoSys Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. MorphoSys market risk premium is the additional return an investor will receive from holding MorphoSys long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in MorphoSys. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate MorphoSys' performance over market.| α | 0.08 | β | -0.09 |
MorphoSys Fundamentals Vs Peers
Comparing MorphoSys' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze MorphoSys' direct or indirect competition across all of the common fundamentals between MorphoSys and the related equities. This way, we can detect undervalued stocks with similar characteristics as MorphoSys or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of MorphoSys' fundamental indicators could also be used in its relative valuation, which is a method of valuing MorphoSys by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare MorphoSys to competition |
| Fundamentals | MorphoSys | Peer Average |
| Return On Equity | -1.84 | -0.31 |
| Return On Asset | -0.14 | -0.14 |
| Profit Margin | (1.91) % | (1.27) % |
| Operating Margin | (9.60) % | (5.51) % |
| Current Valuation | 2.68 B | 16.62 B |
| Shares Outstanding | 150.65 M | 571.82 M |
| Shares Owned By Institutions | 7.44 % | 39.21 % |
MorphoSys Opportunities
MorphoSys Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | MorphoSys stock gains after Novartis discloses all tender offer conditions were met | 05/16/2024 |
2 | MOR STOCK ALERT Halper Sadeh LLC Is Investigating Whether the Sale of MorphoSys AG Is Fair to Shareholders | 06/20/2024 |
3 | Pharmaceutical acquisitions highlight the promise, risk of new drug development - Equities News | 06/25/2024 |
4 | Dave Cantin Group and Kaiser Associates Market Outlook Report-Midyear Update Says EVs Are Here to Stay, Your Local Dealers Might Not Be, and Consumers Will Forc... | 07/30/2024 |
About MorphoSys Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including MorphoSys or other delisted stocks. Alpha measures the amount that position in MorphoSys AG ADR has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
MorphoSys Upcoming Company Events
As portrayed in its financial statements, the presentation of MorphoSys' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, MorphoSys' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of MorphoSys' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of MorphoSys. Please utilize our Beneish M Score to check the likelihood of MorphoSys' management manipulating its earnings.
| 20th of March 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with MorphoSys
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in MorphoSys Stock
If you are still planning to invest in MorphoSys AG ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MorphoSys' history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |